{
    "table_name": "CLINICAL_TIER1_FOLLOWUP_CURRENT",
    "table_fullname": "HTAN_2.HTAN.CLINICAL_TIER1_FOLLOWUP_CURRENT",
    "column_names": [
        "AIDS_RISK_FACTORS",
        "HYSTERECTOMY_MARGINS_INVOLVED",
        "RECIST_TARGETED_REGIONS_NUMBER",
        "MANIFEST_VERSION",
        "KARNOFSKY_PERFORMANCE_STATUS",
        "CAUSE_OF_RESPONSE",
        "MENOPAUSE_STATUS",
        "PROGRESSION_OR_RECURRENCE",
        "ADVERSE_EVENT_GRADE",
        "FEV_1_FVC_PRE_BRONCH_PERCENT",
        "HEIGHT",
        "DAYS_TO_IMAGING",
        "PREGNANCY_OUTCOME",
        "HTAN_CENTER",
        "BARRETTS_ESOPHAGUS_GOBLET_CELLS_PRESENT",
        "RECIST_TARGETED_REGIONS_SUM",
        "HPV_POSITIVE_TYPE",
        "DIABETES_TREATMENT_TYPE",
        "ECOG_PERFORMANCE_STATUS",
        "IMAGING_RESULT",
        "HEPATITIS_SUSTAINED_VIROLOGICAL_RESPONSE",
        "CDC_HIV_RISK_FACTORS",
        "COMPONENT",
        "IMAGING_TYPE",
        "WEIGHT",
        "HYSTERECTOMY_TYPE",
        "DLCO_REF_PREDICTIVE_PERCENT",
        "REFLUX_TREATMENT_TYPE",
        "DAYS_TO_RECURRENCE",
        "HORMONAL_CONTRACEPTIVE_USE",
        "HIV_VIRAL_LOAD",
        "EVIDENCE_OF_RECURRENCE_TYPE",
        "MANIFEST_ID",
        "CD4_COUNT",
        "ENTITYID",
        "BODY_SURFACE_AREA",
        "HAART_TREATMENT_INDICATOR",
        "RISK_FACTOR",
        "ID",
        "FEV1_REF_PRE_BRONCH_PERCENT",
        "BMI",
        "DAYS_TO_FOLLOW_UP",
        "RISK_FACTOR_TREATMENT",
        "NADIR_CD4_COUNT",
        "FEV1_FVC_POST_BRONCH_PERCENT",
        "DAYS_TO_ADVERSE_EVENT",
        "SCAN_TRACER_USED",
        "HTAN_PARTICIPANT_ID",
        "IMMUNOSUPPRESSIVE_TREATMENT_TYPE",
        "COMORBIDITY",
        "ADVERSE_EVENT",
        "PROGRESSION_OR_RECURRENCE_TYPE",
        "DAYS_TO_PROGRESSION_FREE",
        "DAYS_TO_PROGRESSION",
        "VIRAL_HEPATITIS_SEROLOGIES",
        "DISEASE_RESPONSE",
        "DAYS_TO_COMORBIDITY",
        "COMORBIDITY_METHOD_OF_DIAGNOSIS",
        "PROGRESSION_OR_RECURRENCE_ANATOMIC_SITE",
        "FEV1_REF_POST_BRONCH_PERCENT",
        "PANCREATITIS_ONSET_YEAR"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        "The text term used to describe a risk factor of the acquired immunodeficiency syndrome (AIDS) that the patient either had at time time of the study or experienced in the past.",
        "The text term used to indicate whether the patient's disease was determined to be involved based on the surgical margins of the hysterectomy.",
        "Numeric value that represents the number of baseline target lesions, as described by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria",
        "Latest version of metadata manifest",
        "Text term used to describe the classification used of the functional capabilities of a person.",
        "The text term used to describe the suspected cause or reason for the patient disease response.",
        "Text term used to describe the patient's menopause status.",
        "Yes/No/unknown indicator to identify whether a patient has had a new tumor event after initial treatment.",
        "The text term used to describe a specific histone variants, which are proteins that substitute for the core canonical histones.",
        "Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) pre-bronchodilator.",
        "The height of the patient in centimeters.",
        "Number of days between the date used for index and the date the imaging or scan was performed on the patient. If not applicable please enter 'Not Applicable'",
        "The text term used to describe the type of pregnancy the patient had",
        "Name of HTAN Center e.g. HTAN HTAPP",
        "Presence or absennce of Barretts esophagus goblet cells.",
        "Numeric value that represents the sum of baseline target lesions, as described by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria.",
        "Text classification to represent the strain or type of human papillomavirus identified in an individual.",
        "Text term used to describe the types of treatment used to manage diabetes.",
        "The ECOG functional performance status of the patient/participant.",
        "The text term used to describe the result of the imaging or scan performed on the patient.",
        "The yes/no/unknown indicator used to describe whether the patient received treatment for a risk factor the patient had at the time of or prior to their diagnosis.",
        "The text term used to describe a risk factor for human immunodeficiency virus, as described by the Center for Disease Control.",
        "Category of metadata (e.g. Diagnosis, Biospecimen, scRNA-seq Level 1, etc.); provide the same one for all items/rows.",
        "The text term used to describe the type of imaging or scan performed on the patient.",
        "The weight of the patient measured in kilograms.",
        "The text term used to describe the type of hysterectomy the patient had.",
        "The value, as a percentage of predicted lung volume, measuring the amount of carbon monoxide detected in a patient's lungs.",
        "Text term used to describe the types of treatment used to manage gastroesophageal reflux disease (GERD).",
        "Number of days between the date used for index and the date the patient's disease recurred. If not applicable please enter 'Not Applicable'",
        "The text term used to indicate whether the patient used hormonal contraceptives.",
        "Numeric value that represents the concentration of an analyte or aliquot extracted from the sample or sample portion, measured in milligrams per milliliter.",
        "The text term used to describe the type of evidence used to determine whether the patient's disease recurred",
        "Synapse ID of manifest containing file annotation",
        "The text term used to describe the outcome of the procedure to determine the amount of the CD4 expressing cells in a sample.",
        "Synapse ID of entity",
        "Numeric value used to represent the 2-dimensional extent of the body surface relating height to weight.",
        "The text term used to indicate whether the patient received Highly Active Antiretroviral Therapy (HAART).",
        "The text term used to describe a risk factor the patient had at the time of or prior to their diagnosis.",
        "Unique identifier of entity e.g. a96059eb-81af-4b24-ae50-9242c0d8f819",
        "The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second pre-bronchodilator.",
        "A calculated numerical quantity that represents an individual's weight to height ratio.",
        "Number of days between the date used for index and the date of the patient's last follow-up appointment or contact. If not applicable please enter 'Not Applicable'",
        "The yes/no/unknown indicator used to describe whether the patient received treatment for a risk factor the patient had at the time of or prior to their diagnosis.",
        "Numeric value that represents the lowest point to which the CD4 count has dropped (nadir).",
        "Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) post-bronchodilator.",
        "Number of days between the date used for index and the date of the patient's adverse event. If not applicable please enter 'Not Applicable'",
        "The text term used to describe the type of tracer used during the imaging or scan of the patient.",
        "HTAN ID associated with a patient based on HTAN ID SOP (eg HTANx_yyy )",
        "The text term used to describe the type of immunosuppresive treatment the patient received.",
        "The text term used to describe a comorbidity disease, which coexists with the patient's malignant disease.",
        "Text that represents the Common Terminology Criteria for Adverse Events low level term name for an adverse event.",
        "The text term used to describe the type of progressive or recurrent disease or relapsed disease.",
        "Number of days between the date used for index and the date the patient's disease was formally confirmed as progression-free. If not applicable please enter 'Not Applicable'",
        "Number of days between the date used for index and the date the patient's disease progressed. If not applicable please enter 'Not Applicable'",
        "Text term that describes the kind of serological laboratory test used to determine the patient's hepatitus status.",
        "Code assigned to describe the patient's response or outcome to the disease.",
        "Number of days between the date used for index and the date the patient was diagnosed with a comorbidity. If not applicable please enter 'Not Applicable'",
        "The text term used to describe the method used to diagnose the patient's comorbidity disease.",
        "The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment",
        "The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second post-bronchodilator.",
        "Date of onset of pancreatitis."
    ],
    "sample_rows": [
        {
            "HEPATITIS_SUSTAINED_VIROLOGICAL_RESPONSE": null,
            "IMMUNOSUPPRESSIVE_TREATMENT_TYPE": null,
            "PROGRESSION_OR_RECURRENCE_TYPE": null,
            "REFLUX_TREATMENT_TYPE": null,
            "NADIR_CD4_COUNT": null,
            "DAYS_TO_PROGRESSION": null,
            "HYSTERECTOMY_MARGINS_INVOLVED": null,
            "PROGRESSION_OR_RECURRENCE": "Yes - Progression or Recurrence",
            "IMAGING_TYPE": null,
            "DAYS_TO_PROGRESSION_FREE": null,
            "COMPONENT": "FollowUp",
            "RISK_FACTOR_TREATMENT": null,
            "DAYS_TO_COMORBIDITY": null,
            "SCAN_TRACER_USED": null,
            "PROGRESSION_OR_RECURRENCE_ANATOMIC_SITE": null,
            "ECOG_PERFORMANCE_STATUS": null,
            "IMAGING_RESULT": null,
            "CDC_HIV_RISK_FACTORS": null,
            "CAUSE_OF_RESPONSE": null,
            "HEIGHT": null,
            "DAYS_TO_ADVERSE_EVENT": null,
            "FEV1_REF_PRE_BRONCH_PERCENT": null,
            "COMORBIDITY_METHOD_OF_DIAGNOSIS": null,
            "HPV_POSITIVE_TYPE": null,
            "COMORBIDITY": null,
            "HIV_VIRAL_LOAD": null,
            "DISEASE_RESPONSE": null,
            "DAYS_TO_FOLLOW_UP": "18657",
            "ADVERSE_EVENT": null,
            "BARRETTS_ESOPHAGUS_GOBLET_CELLS_PRESENT": null,
            "AIDS_RISK_FACTORS": null,
            "HYSTERECTOMY_TYPE": null,
            "PREGNANCY_OUTCOME": null,
            "ENTITYID": "syn24997476",
            "WEIGHT": null,
            "DLCO_REF_PREDICTIVE_PERCENT": null,
            "FEV1_FVC_POST_BRONCH_PERCENT": null,
            "VIRAL_HEPATITIS_SEROLOGIES": null,
            "DIABETES_TREATMENT_TYPE": null,
            "FEV_1_FVC_PRE_BRONCH_PERCENT": null,
            "KARNOFSKY_PERFORMANCE_STATUS": null,
            "RISK_FACTOR": null,
            "BODY_SURFACE_AREA": null,
            "HTAN_PARTICIPANT_ID": "HTA12_6",
            "PANCREATITIS_ONSET_YEAR": null,
            "EVIDENCE_OF_RECURRENCE_TYPE": null,
            "HAART_TREATMENT_INDICATOR": null,
            "RECIST_TARGETED_REGIONS_SUM": null,
            "CD4_COUNT": null,
            "DAYS_TO_RECURRENCE": "18411.0",
            "ADVERSE_EVENT_GRADE": null,
            "ID": "b84b710c-3b7d-410e-81e9-fe4aa13cc427",
            "FEV1_REF_POST_BRONCH_PERCENT": null,
            "HORMONAL_CONTRACEPTIVE_USE": null,
            "MENOPAUSE_STATUS": null,
            "RECIST_TARGETED_REGIONS_NUMBER": null,
            "DAYS_TO_IMAGING": null,
            "BMI": null,
            "HTAN_CENTER": "HTAN WUSTL",
            "MANIFEST_ID": "syn39168815",
            "MANIFEST_VERSION": 1
        },
        {
            "HEPATITIS_SUSTAINED_VIROLOGICAL_RESPONSE": null,
            "IMMUNOSUPPRESSIVE_TREATMENT_TYPE": null,
            "PROGRESSION_OR_RECURRENCE_TYPE": null,
            "REFLUX_TREATMENT_TYPE": null,
            "NADIR_CD4_COUNT": null,
            "DAYS_TO_PROGRESSION": null,
            "HYSTERECTOMY_MARGINS_INVOLVED": null,
            "PROGRESSION_OR_RECURRENCE": "Yes - Progression or Recurrence",
            "IMAGING_TYPE": null,
            "DAYS_TO_PROGRESSION_FREE": null,
            "COMPONENT": "FollowUp",
            "RISK_FACTOR_TREATMENT": null,
            "DAYS_TO_COMORBIDITY": null,
            "SCAN_TRACER_USED": null,
            "PROGRESSION_OR_RECURRENCE_ANATOMIC_SITE": null,
            "ECOG_PERFORMANCE_STATUS": null,
            "IMAGING_RESULT": null,
            "CDC_HIV_RISK_FACTORS": null,
            "CAUSE_OF_RESPONSE": null,
            "HEIGHT": null,
            "DAYS_TO_ADVERSE_EVENT": null,
            "FEV1_REF_PRE_BRONCH_PERCENT": null,
            "COMORBIDITY_METHOD_OF_DIAGNOSIS": null,
            "HPV_POSITIVE_TYPE": null,
            "COMORBIDITY": null,
            "HIV_VIRAL_LOAD": null,
            "DISEASE_RESPONSE": null,
            "DAYS_TO_FOLLOW_UP": "25188",
            "ADVERSE_EVENT": null,
            "BARRETTS_ESOPHAGUS_GOBLET_CELLS_PRESENT": null,
            "AIDS_RISK_FACTORS": null,
            "HYSTERECTOMY_TYPE": null,
            "PREGNANCY_OUTCOME": null,
            "ENTITYID": "syn24997478",
            "WEIGHT": null,
            "DLCO_REF_PREDICTIVE_PERCENT": null,
            "FEV1_FVC_POST_BRONCH_PERCENT": null,
            "VIRAL_HEPATITIS_SEROLOGIES": null,
            "DIABETES_TREATMENT_TYPE": null,
            "FEV_1_FVC_PRE_BRONCH_PERCENT": null,
            "KARNOFSKY_PERFORMANCE_STATUS": null,
            "RISK_FACTOR": null,
            "BODY_SURFACE_AREA": null,
            "HTAN_PARTICIPANT_ID": "HTA12_7",
            "PANCREATITIS_ONSET_YEAR": null,
            "EVIDENCE_OF_RECURRENCE_TYPE": null,
            "HAART_TREATMENT_INDICATOR": null,
            "RECIST_TARGETED_REGIONS_SUM": null,
            "CD4_COUNT": null,
            "DAYS_TO_RECURRENCE": "25118.0",
            "ADVERSE_EVENT_GRADE": null,
            "ID": "0b87925c-9e8a-4c06-af9d-742c67134c54",
            "FEV1_REF_POST_BRONCH_PERCENT": null,
            "HORMONAL_CONTRACEPTIVE_USE": null,
            "MENOPAUSE_STATUS": null,
            "RECIST_TARGETED_REGIONS_NUMBER": null,
            "DAYS_TO_IMAGING": null,
            "BMI": null,
            "HTAN_CENTER": "HTAN WUSTL",
            "MANIFEST_ID": "syn39168815",
            "MANIFEST_VERSION": 1
        },
        {
            "HEPATITIS_SUSTAINED_VIROLOGICAL_RESPONSE": null,
            "IMMUNOSUPPRESSIVE_TREATMENT_TYPE": null,
            "PROGRESSION_OR_RECURRENCE_TYPE": null,
            "REFLUX_TREATMENT_TYPE": null,
            "NADIR_CD4_COUNT": null,
            "DAYS_TO_PROGRESSION": null,
            "HYSTERECTOMY_MARGINS_INVOLVED": null,
            "PROGRESSION_OR_RECURRENCE": "Yes - Progression or Recurrence",
            "IMAGING_TYPE": null,
            "DAYS_TO_PROGRESSION_FREE": null,
            "COMPONENT": "FollowUp",
            "RISK_FACTOR_TREATMENT": null,
            "DAYS_TO_COMORBIDITY": null,
            "SCAN_TRACER_USED": null,
            "PROGRESSION_OR_RECURRENCE_ANATOMIC_SITE": null,
            "ECOG_PERFORMANCE_STATUS": null,
            "IMAGING_RESULT": null,
            "CDC_HIV_RISK_FACTORS": null,
            "CAUSE_OF_RESPONSE": null,
            "HEIGHT": null,
            "DAYS_TO_ADVERSE_EVENT": null,
            "FEV1_REF_PRE_BRONCH_PERCENT": null,
            "COMORBIDITY_METHOD_OF_DIAGNOSIS": null,
            "HPV_POSITIVE_TYPE": null,
            "COMORBIDITY": null,
            "HIV_VIRAL_LOAD": null,
            "DISEASE_RESPONSE": null,
            "DAYS_TO_FOLLOW_UP": "22751",
            "ADVERSE_EVENT": null,
            "BARRETTS_ESOPHAGUS_GOBLET_CELLS_PRESENT": null,
            "AIDS_RISK_FACTORS": null,
            "HYSTERECTOMY_TYPE": null,
            "PREGNANCY_OUTCOME": null,
            "ENTITYID": "syn25050445",
            "WEIGHT": null,
            "DLCO_REF_PREDICTIVE_PERCENT": null,
            "FEV1_FVC_POST_BRONCH_PERCENT": null,
            "VIRAL_HEPATITIS_SEROLOGIES": null,
            "DIABETES_TREATMENT_TYPE": null,
            "FEV_1_FVC_PRE_BRONCH_PERCENT": null,
            "KARNOFSKY_PERFORMANCE_STATUS": null,
            "RISK_FACTOR": null,
            "BODY_SURFACE_AREA": null,
            "HTAN_PARTICIPANT_ID": "HTA6_11",
            "PANCREATITIS_ONSET_YEAR": null,
            "EVIDENCE_OF_RECURRENCE_TYPE": null,
            "HAART_TREATMENT_INDICATOR": null,
            "RECIST_TARGETED_REGIONS_SUM": null,
            "CD4_COUNT": null,
            "DAYS_TO_RECURRENCE": "21899",
            "ADVERSE_EVENT_GRADE": null,
            "ID": "40ea3a91-1bca-4f2c-b35c-09f6418e003a",
            "FEV1_REF_POST_BRONCH_PERCENT": null,
            "HORMONAL_CONTRACEPTIVE_USE": null,
            "MENOPAUSE_STATUS": null,
            "RECIST_TARGETED_REGIONS_NUMBER": null,
            "DAYS_TO_IMAGING": null,
            "BMI": null,
            "HTAN_CENTER": "HTAN Duke",
            "MANIFEST_ID": "syn39265732",
            "MANIFEST_VERSION": 6
        },
        {
            "HEPATITIS_SUSTAINED_VIROLOGICAL_RESPONSE": null,
            "IMMUNOSUPPRESSIVE_TREATMENT_TYPE": null,
            "PROGRESSION_OR_RECURRENCE_TYPE": null,
            "REFLUX_TREATMENT_TYPE": null,
            "NADIR_CD4_COUNT": null,
            "DAYS_TO_PROGRESSION": null,
            "HYSTERECTOMY_MARGINS_INVOLVED": null,
            "PROGRESSION_OR_RECURRENCE": "Yes - Progression or Recurrence",
            "IMAGING_TYPE": null,
            "DAYS_TO_PROGRESSION_FREE": null,
            "COMPONENT": "FollowUp",
            "RISK_FACTOR_TREATMENT": null,
            "DAYS_TO_COMORBIDITY": null,
            "SCAN_TRACER_USED": null,
            "PROGRESSION_OR_RECURRENCE_ANATOMIC_SITE": null,
            "ECOG_PERFORMANCE_STATUS": null,
            "IMAGING_RESULT": null,
            "CDC_HIV_RISK_FACTORS": null,
            "CAUSE_OF_RESPONSE": null,
            "HEIGHT": null,
            "DAYS_TO_ADVERSE_EVENT": null,
            "FEV1_REF_PRE_BRONCH_PERCENT": null,
            "COMORBIDITY_METHOD_OF_DIAGNOSIS": null,
            "HPV_POSITIVE_TYPE": null,
            "COMORBIDITY": null,
            "HIV_VIRAL_LOAD": null,
            "DISEASE_RESPONSE": null,
            "DAYS_TO_FOLLOW_UP": "19743",
            "ADVERSE_EVENT": null,
            "BARRETTS_ESOPHAGUS_GOBLET_CELLS_PRESENT": null,
            "AIDS_RISK_FACTORS": null,
            "HYSTERECTOMY_TYPE": null,
            "PREGNANCY_OUTCOME": null,
            "ENTITYID": "syn25050446",
            "WEIGHT": null,
            "DLCO_REF_PREDICTIVE_PERCENT": null,
            "FEV1_FVC_POST_BRONCH_PERCENT": null,
            "VIRAL_HEPATITIS_SEROLOGIES": null,
            "DIABETES_TREATMENT_TYPE": null,
            "FEV_1_FVC_PRE_BRONCH_PERCENT": null,
            "KARNOFSKY_PERFORMANCE_STATUS": null,
            "RISK_FACTOR": null,
            "BODY_SURFACE_AREA": null,
            "HTAN_PARTICIPANT_ID": "HTA6_13",
            "PANCREATITIS_ONSET_YEAR": null,
            "EVIDENCE_OF_RECURRENCE_TYPE": null,
            "HAART_TREATMENT_INDICATOR": null,
            "RECIST_TARGETED_REGIONS_SUM": null,
            "CD4_COUNT": null,
            "DAYS_TO_RECURRENCE": "16368",
            "ADVERSE_EVENT_GRADE": null,
            "ID": "43df5264-5181-4409-a9d1-b2c6f643a3ba",
            "FEV1_REF_POST_BRONCH_PERCENT": null,
            "HORMONAL_CONTRACEPTIVE_USE": null,
            "MENOPAUSE_STATUS": null,
            "RECIST_TARGETED_REGIONS_NUMBER": null,
            "DAYS_TO_IMAGING": null,
            "BMI": null,
            "HTAN_CENTER": "HTAN Duke",
            "MANIFEST_ID": "syn39265732",
            "MANIFEST_VERSION": 6
        },
        {
            "HEPATITIS_SUSTAINED_VIROLOGICAL_RESPONSE": null,
            "IMMUNOSUPPRESSIVE_TREATMENT_TYPE": null,
            "PROGRESSION_OR_RECURRENCE_TYPE": null,
            "REFLUX_TREATMENT_TYPE": null,
            "NADIR_CD4_COUNT": null,
            "DAYS_TO_PROGRESSION": null,
            "HYSTERECTOMY_MARGINS_INVOLVED": null,
            "PROGRESSION_OR_RECURRENCE": "Yes - Progression or Recurrence",
            "IMAGING_TYPE": null,
            "DAYS_TO_PROGRESSION_FREE": null,
            "COMPONENT": "FollowUp",
            "RISK_FACTOR_TREATMENT": null,
            "DAYS_TO_COMORBIDITY": null,
            "SCAN_TRACER_USED": null,
            "PROGRESSION_OR_RECURRENCE_ANATOMIC_SITE": null,
            "ECOG_PERFORMANCE_STATUS": null,
            "IMAGING_RESULT": null,
            "CDC_HIV_RISK_FACTORS": null,
            "CAUSE_OF_RESPONSE": null,
            "HEIGHT": null,
            "DAYS_TO_ADVERSE_EVENT": null,
            "FEV1_REF_PRE_BRONCH_PERCENT": null,
            "COMORBIDITY_METHOD_OF_DIAGNOSIS": null,
            "HPV_POSITIVE_TYPE": null,
            "COMORBIDITY": null,
            "HIV_VIRAL_LOAD": null,
            "DISEASE_RESPONSE": null,
            "DAYS_TO_FOLLOW_UP": "22597",
            "ADVERSE_EVENT": null,
            "BARRETTS_ESOPHAGUS_GOBLET_CELLS_PRESENT": null,
            "AIDS_RISK_FACTORS": null,
            "HYSTERECTOMY_TYPE": null,
            "PREGNANCY_OUTCOME": null,
            "ENTITYID": "syn25050447",
            "WEIGHT": null,
            "DLCO_REF_PREDICTIVE_PERCENT": null,
            "FEV1_FVC_POST_BRONCH_PERCENT": null,
            "VIRAL_HEPATITIS_SEROLOGIES": null,
            "DIABETES_TREATMENT_TYPE": null,
            "FEV_1_FVC_PRE_BRONCH_PERCENT": null,
            "KARNOFSKY_PERFORMANCE_STATUS": null,
            "RISK_FACTOR": null,
            "BODY_SURFACE_AREA": null,
            "HTAN_PARTICIPANT_ID": "HTA6_14",
            "PANCREATITIS_ONSET_YEAR": null,
            "EVIDENCE_OF_RECURRENCE_TYPE": null,
            "HAART_TREATMENT_INDICATOR": null,
            "RECIST_TARGETED_REGIONS_SUM": null,
            "CD4_COUNT": null,
            "DAYS_TO_RECURRENCE": "21746",
            "ADVERSE_EVENT_GRADE": null,
            "ID": "c9f9b325-9421-47e5-932e-b2c9bbb7af2c",
            "FEV1_REF_POST_BRONCH_PERCENT": null,
            "HORMONAL_CONTRACEPTIVE_USE": null,
            "MENOPAUSE_STATUS": null,
            "RECIST_TARGETED_REGIONS_NUMBER": null,
            "DAYS_TO_IMAGING": null,
            "BMI": null,
            "HTAN_CENTER": "HTAN Duke",
            "MANIFEST_ID": "syn39265732",
            "MANIFEST_VERSION": 6
        }
    ]
}